SCHEMBL16112948

SCHEMBL16112948

CC(C)(CN1CCCCC1)Oc1ccccc1N

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 1/20 0.45
▸ CYP2D6 P10635 2/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ HRH3 Q9Y5N1 2/20 0.41
▸ SLC6A3 Q01959 4/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ DRD2 P14416 3/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.39
▸ SLC6A2 P23975 2/20 0.38
▸ TDP1 Q9NUW8 2/20 0.38
▸ ADRA2B P18089 1/20 0.38
▸ PTGS1 P23219 1/20 0.38
▸ KEAP1 Q14145 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ CHRM2 P08172 1/20 0.37
▸ HTR1A P08908 1/20 0.37
▸ ADRA2A P08913 1/20 0.37
▸ CHRM1 P11229 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16112300 0.75 ALDH1A1 (0.46) LTA4HHSD17B10HRH3SLC6A3ALDH1A1
SCHEMBL15458084 0.73 ALDH1A1 (0.53) CYP2C19CYP1A2HSD17B10ALDH1A1TDP1
SCHEMBL293944 0.72 ALDH1A1 (0.47) CYP2C19CYP1A2HSD17B10ALDH1A1TDP1
SCHEMBL1027777 0.70 LTA4H (0.71) LTA4HCYP2D6CYP2C19CYP1A2HSD17B10
SCHEMBL16112920 0.69 ATM (0.49) LTA4HHRH3TDP1KDM4ESIGMAR1
SCHEMBL1808547 0.68 ALDH1A1 (0.56) CYP2C19CYP1A2ALDH1A1TDP1ADRA2B
SCHEMBL30150794 0.68 LTA4H (0.73) LTA4HCYP2D6CYP2C19CYP1A2HSD17B10
SCHEMBL1031593 0.68 LTA4H (0.73) LTA4HCYP2D6CYP2C19CYP1A2HSD17B10
SCHEMBL3580933 0.67 ACVR1 (0.36) HRH3SLC6A3ALDH1A1KDM4ESLC6A4
SCHEMBL3571206 0.67 ATM (0.46) LTA4HHRH3TDP1KDM4ESIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970311-A2 BMP INHIBITORS AND METHODS OF USE THEREOF The Brigham and Women's Hospital, Inc. (US) 2016-01-20 — — EP disclosed
WO-2014160203-A2 BMP INHIBITORS AND METHODS OF USE THEREOF THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2014-10-02 — — WO disclosed
Send feedback